| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,525 | 26,263 | 28,461 | 44,149 | | Cost of Revenue | 7,126 | 8,404 | 15,292 | 15,590 | | | Gross Profit | 16,399 | 17,859 | 13,169 | 28,559 | | | Operating Expenses | | Research Development | (5,179) | 5,179 |
-
|
-
| | Selling General and Administrative | 10,633 | 6,713 | 7,057 | 6,687 | | Non Recurring | 6,917 | 23,377 |
-
| 27,515 | | Others | 42,063 | 36,537 | 33,658 | 26,591 | | | | Total Operating Expenses | 54,434 | 71,806 |
-
|
-
| | | | Operating Income or Loss | (37,740) | (53,947) | (27,546) | (32,234) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,246) | 2,700 | 37,245 | 42,428 | | Earnings Before Interest And Taxes | (39,281) | (51,247) | 9,699 | 10,194 | | Interest Expense | 6,646 | 5,298 | 5,208 | 3,803 | | Income Before Tax | (45,927) | (56,545) | 4,491 | 6,391 | | Income Tax Expense | (16,394) | (21,505) | 1,354 | 4,427 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (29,533) | (35,040) | 3,137 | 1,964 | | | Non-recurring Events | | Discontinued Operations | 14 | 58 | 7 | (770) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (29,519) | (34,982) | 3,144 | 1,194 | | Preferred Stock And Other Adjustments | (1,512) | (1,512) | (1,512) | (1,512) | | | Net Income Applicable To Common Shares | ($31,031) | ($36,494) | $1,632 | ($318) |
|
1.27% Nasdaq 0.00%
Income Statement
